From PCR to oncology - Roche's pharma journey
In the first of a series of interviews with in-house counsel, Managing IP spoke to Eric Notegen, head of the global patent function at F Hoffmann-La Roche, about his long career at the company, patent reform in the US and the future of the pharmaceutical industry worldwide. By Eklavya Gupte
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
